ArticleImmunity2025

Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer.

Dig B Mahat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.